tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech Plans Jurisdiction Shift to Nevada
Company AnnouncementsOncolytics Biotech Plans Jurisdiction Shift to Nevada
19h ago
ONCY
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy
PremiumCompany Announcements
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy
10d ago
6K
ONCY
Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design
PremiumCompany Announcements
Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design
22d ago
ONCY
Positive Outlook for Oncolytics Biotech Amidst Strategic Advancements and Sector Growth
PremiumRatings
Positive Outlook for Oncolytics Biotech Amidst Strategic Advancements and Sector Growth
1M ago
ONCY
Oncolytics Biotech Expands GOBLET Study to U.S., Shows Promising Results
PremiumCompany Announcements
Oncolytics Biotech Expands GOBLET Study to U.S., Shows Promising Results
1M ago
ONCY
Oncolytics provides update on study of pelareorep in gastrointestinal cancers
PremiumThe FlyOncolytics provides update on study of pelareorep in gastrointestinal cancers
1M ago
ONCY
Promising Outlook for Oncolytics Biotech: Buy Rating Backed by Strong Clinical Data and Strategic Catalysts
Premium
Ratings
Promising Outlook for Oncolytics Biotech: Buy Rating Backed by Strong Clinical Data and Strategic Catalysts
1M ago
ONCY
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies
Premium
Company Announcements
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies
1M ago
6K
ONCY
Oncolytics announces results from three mCRC studies
PremiumThe Fly
Oncolytics announces results from three mCRC studies
1M ago
ONCY
Oncolytics Biotech Updates Pelareorep Safety Data for Gastrointestinal Tumors
PremiumCompany Announcements
Oncolytics Biotech Updates Pelareorep Safety Data for Gastrointestinal Tumors
2M ago
6K
ONCY
Oncolytics provides updated clinical safety data for pelareorep
PremiumThe Fly
Oncolytics provides updated clinical safety data for pelareorep
2M ago
ONCY
Oncolytics Biotech to Participate in September Investor Conferences
PremiumCompany Announcements
Oncolytics Biotech to Participate in September Investor Conferences
2M ago
6K
ONCY
Oncolytics initiated with a Buy at Lake Street
PremiumThe FlyOncolytics initiated with a Buy at Lake Street
2M ago
ONCY
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep
Premium
Ratings
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep
2M ago
ONCY
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating
Premium
Ratings
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating
2M ago
ONCY
Oncolytics Biotech Announces AGM Voting Results
PremiumCompany Announcements
Oncolytics Biotech Announces AGM Voting Results
2M ago
6K
ONCY
Oncolytics Biotech Advances Pelareorep with Strategic Moves
PremiumCompany Announcements
Oncolytics Biotech Advances Pelareorep with Strategic Moves
2M ago
ONCY
Oncolytics Biotech to Delist from TSX, Focus on Nasdaq
PremiumCompany Announcements
Oncolytics Biotech to Delist from TSX, Focus on Nasdaq
2M ago
6K
ONCY
Oncolytics Biotech Advances Pelareorep Clinical Program with Strategic Moves
PremiumCompany Announcements
Oncolytics Biotech Advances Pelareorep Clinical Program with Strategic Moves
2M ago
6K
ONCY
Oncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update
PremiumCompany AnnouncementsOncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update
2M ago
6K
ONCY
Oncolytics Biotech Files SEC Report Incorporating Information Circular
Premium
Company Announcements
Oncolytics Biotech Files SEC Report Incorporating Information Circular
2M ago
6K
ONCY
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
Premium
The Fly
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
2M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >